STOCK TITAN

Immunic, Inc. (IMUX) Net Income by Year

IMUX

Immunic, Inc. reported a net loss of $97.2M in fiscal year 2025. This represents an increase of 3.3% from the prior fiscal year. The table below carries 14 fiscal years, from 2012 to 2025, and the quarters Immunic, Inc. has filed alongside them.

FY2025 annual
Net Income -$97.2M
YoY +3.3%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

IMUX Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-K
Net Income-$97.2M+3.3%-$100.5M-7.4%-$93.6M+22.3%-$120.4M-29.5%-$92.9M-111.2%-$44.0M-26.0%-$34.9M-202.7%-$11.5M+77.8%-$52.1M-27.1%-$41.0M+21.2%-$52.0M-9.1%-$47.7M-45.7%-$32.7M-388.3%-$6.7M

IMUX Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
Net Income-$34.1M-27.1%-$32.6M-27.9%N/A-$25.6M-5.0%-$26.8M-25.4%-$25.5M+13.9%N/A-$24.4M-7.0%-$21.4M+10.9%-$29.6M-17.1%N/A-$22.8M-7.3%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Immunic, Inc. financials

Frequently Asked Questions

What was Immunic, Inc.'s net income in fiscal year 2025?

Immunic, Inc. reported a net loss of $97.2M in fiscal year 2025.

How fast is Immunic, Inc.'s net income growing?

Immunic, Inc. (IMUX) net income rose by 3.3% year over year, from -$100.5M to -$97.2M in fiscal year 2025.

How has Immunic, Inc.'s net income changed over the years?

Across the 14 fiscal years this page covers, Immunic, Inc. (IMUX) net income went from -$6.7M in fiscal year 2012 to -$97.2M in fiscal year 2025.

Immunic, Inc. (IMUX) reported -$34.1M in net income in Q2 2026. This represents a decrease of 27.1% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Immunic, Inc. (IMUX) reported on that line in every period on record.